ENTRY       D11517                      Drug
NAME        Abicipar pegol (USAN/INN);
            Abicipar pegol (genetical recombination) (JAN)
FORMULA     C628H985N175O203S2 (C2H4O)n
SEQUENCE    GSDLDKKLLE AARAGQDDEV RILMANGADV NARDSTGWTP LHLAAPWGHP EIVEVLLKNG
            ADVNAADFQG WTPLHLAAAV GHLEIVEVLL KYGADVNAQD KFGKTAFDIS IDNGNEDLAE
            ILQKAAGGGS GGGSC
  TYPE      Peptide
REMARK      ATC code: S01LA07
EFFICACY    Macular degeneration therapeutic agent
COMMENT     Treatment of neovascular wet age-related macular degeneration and diabetic macular edema
TARGET      VEGFA [HSA:7422] [KO:K05448]
  PATHWAY   hsa04370(7422)  VEGF signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01L OCULAR VASCULAR DISORDER AGENTS
                S01LA Antineovascularisation agents
                 S01LA07 Abicipar pegol
                  D11517  Abicipar pegol (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                VEGFA
                 D11517  Abicipar pegol (USAN/INN)
DBLINKS     CAS: 1327278-94-3
            PubChem: 384585493
///
